Hostname: page-component-5c6d5d7d68-tdptf Total loading time: 0 Render date: 2024-08-16T00:26:36.286Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychiatrists are stakeholders in improving access to controlled medicines

Published online by Cambridge University Press:  02 January 2018

Willem Scholten
Willem Scholten*
Affiliation:
Access to Controlled Medicines, Department of Essential Medicines and Pharmaceutical Policies, World Health Organization, Geneva, Switzerland, email ScholtenW@who.int
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Medicines made from substances that are controlled under the international drug control treaties (‘controlled medicines’) are out of reach for the majority of patients around the world. Seya et al (2011) demonstrated that 5.5 billion people (83% of the world's population) live in countries with little or no access to opioid analgesics, 250 million (4%) have moderate access and only 460 million people (7%) have adequate access. Insufficient data are available for 430 million (7%). If the need for treatment of moderate to severe pain were to be satisfied adequately, the global consumption of strong opioid analgesics would go up from 231 tonnes of morphine-equivalents to 1292 tonnes.

Type
Special Papers
Information
International Psychiatry , Volume 8 , Issue 4 , November 2011 , pp. 98 - 100
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Royal College of Psychiatrists 2011

References

Commission on Narcotic Drugs (2010) Resolution 53/4: Promoting adequate availability of internationally controlled licit drugs for medical and scientific purposes while preventing their diversion and abuse. Tenth plenary meeting. At http://www.unodc.org/documents/commissions/CND-Res-2000-until-present/CND53_4e.pdf (accessed 4 January 2011).Google Scholar
Human Rights Watch (2009) Please, Do Not Make Us Suffer Any More… Access to Pain Treatment as a Human Right. Human Rights Watch. At http://www.hrw.org/sites/default/files/reports/health0309web_1.pdf (accessed 8 February 2011).Google Scholar
Noble, M., Tregear, S. J., Treadwell, J. R., et al (2008) Long-term opioid therapy for chronic non-cancer pain: a systematic review and meta-analysis of efficacy and safety. Journal of Pain and Symptom Management, 35, 214–228.CrossRefGoogle Scholar
Open Society Institute (2008) Harm Reduction Developments 2008. Countries with Injection-Driven HIV Epidemics. At http://www.soros.org/initiatives/health/focus/ihrd/articles_publications/publications/developments_20080304/developments_20080304.pdf (accessed 8 February 2011).Google Scholar
Seya, M. J., Gelders, S. F. A. M., Achara, O. U., et al (2011) A first comparison between the consumption of and the need for opioid analgesics at country, regional and global level. Journal of Pain and Palliative Care Pharmacotherapy, 25, 6–18.CrossRefGoogle Scholar
United Nations (2005) Resolution ECOSOC 2005/25. Treatment of pain using opioid analgesics. Thirty-sixth plenary meeting. At http://www.un.org/docs/ecosoc/documents/2005/resolutions/Resolution%202005-25.pdf (accessed 5 January 2011).Google Scholar
United Nations (2010) Report of the International Narcotics Control Board for 2009. Paragraph 789. UN. At http://www.incb.org/pdf/annual-report/2009/en/AR_09_English.pdf (accessed 5 January 2011).Google Scholar
World Health Organization (2005) Resolution WHA 58.22. Cancer prevention and control. World Health Assembly 58. At http://www.who.int/ipcs/publications/wha/cancer_resolution.pdf (assessed 5 January 2011).Google Scholar
World Health Organization (2008) Scaling Up Care for Mental, Neurological, and Substance Use Disorders. Mental Health Gap Action Programme. WHO. At http://whqlibdoc.who.int/publications/2008/9789241596206_eng.pdf (accessed 5 January 2011).Google Scholar
World Health Organization (2009) Access to Controlled Medications Programme: improving access to medications under international drug conventions. Briefing note. WHO. At http://www.who.int/medicines/areas/quality_safety/ACMP_BrNoteGenrl_EN_Feb09.pdf (accessed 5 January 2011).Google Scholar
World Health Organization (2011) Ensuring Balance in National Policies on Controlled Substances: Guidance for Accessibility and Availability for Controlled Medicines. WHO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.